Adverse reactions to vaccines practice parameter 2012 update

JM Kelso, MJ Greenhawt, JT Li, RA Nicklas… - Journal of Allergy and …, 2012 - jacionline.org
KELSO ET AL 27 allergy. Only for patients with a history of allergic reaction to influenza
vaccine itself is additional evaluation appropriate, including skin testing with the vaccine and …

Vaccination of healthcare workers: A review

S Haviari, T Bénet, M Saadatian-Elahi… - Human vaccines & …, 2015 - Taylor & Francis
Vaccine-preventable diseases are a significant cause of morbidity and mortality. As new
vaccines are proving to be effective and as the incidence of some infections decreases …

[HTML][HTML] Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices …

JL Liang - MMWR. Recommendations and reports, 2018 - cdc.gov
This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria …

[HTML][HTML] Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women—Advisory …

M Sawyer, JL Liang, N Messonnier… - Morbidity and Mortality …, 2013 - ncbi.nlm.nih.gov
Methods In monthly teleconferences during 2012, the ACIP Pertussis Vaccines Work Group
considered published, peer-reviewed literature and unpublished data relevant to …

[HTML][HTML] Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization …

FP Havers - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Background Two Tdap vaccines are licensed for use in the United States. Boostrix
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …

Rationale for pertussis booster vaccination throughout life in Europe

F Zepp, U Heininger, J Mertsola… - The Lancet infectious …, 2011 - thelancet.com
Although the introduction of universal pertussis immunisation in infants has greatly reduced
the number of reported cases in infants and young children, disease incidence has been …

Pertussis re-emergence in the post-vaccination era

E Chiappini, A Stival, L Galli, M De Martino - BMC infectious diseases, 2013 - Springer
Background Resurgence of pertussis in the post-vaccination era has been reported in
Western countries. A shift of cases from school-age children to adolescents, adults and …

[HTML][HTML] Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on …

KR Broder, KH Brown - MMWR. Morbidity and mortality weekly report, 2011 - stacks.cdc.gov
Despite sustained high coverage for childhood pertussis vaccination, pertussis remains
poorly controlled in the United States. A total of 16,858 pertussis cases and 12 infant deaths …

Recommended vaccinations for asplenic and hyposplenic adult patients

P Bonanni, M Grazzini, G Niccolai… - Human vaccines & …, 2017 - Taylor & Francis
Asplenic or hyposplenic (AH) individuals are particularly vulnerable to invasive infections
caused by encapsulated bacteria. Such infections have often a sudden onset and a …

[HTML][HTML] Factors associated with intention to receive influenza and tetanus, diphtheria, and acellular pertussis (Tdap) vaccines during pregnancy: a focus on vaccine …

AT Chamberlain, K Seib, KA Ault, WA Orenstein… - PLoS …, 2015 - ncbi.nlm.nih.gov
BACKGROUND: Improving influenza and tetanus, diphtheria and acellular pertussis (Tdap)
vaccine coverage among pregnant women is needed. PURPOSE: To assess factors …